CAS:100488-87-7
品牌:MedChemExpress (MCE)
存储条件:Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性:CV-6209 是一种有效的血小板活化因子 (PAF) 拮抗剂。 CV-6209 抑制 PAF 诱导的兔和人血小板聚集,IC50 分别为 75 nM 和 170 nM。 CV-6209 可抑制 PAF 引起的大鼠低血压[1]。 IC50 和目标:血小板活化因子 (PAF)[1]
体外:CV-6209 抑制用 PAF (30 nM) 刺激的兔血小板释放 [3H] 血清素[1]。
CV-6209 对血小板几乎没有作用花生四烯酸、ADP 或胶原诱导的聚集[1]。
CV-6209(0.2-2 μM;预处理 30 分钟)抑制 LAD2 和 hLMC 中 PAF 诱导的 MC 脱颗粒[1]。
体内:CV-6209 (iv) 抑制 PAF (0.3 μg/kg; iv) 引起的大鼠低血压 (ED50=0.009 mg/kg),对花生四烯酸、组胺、缓激肽和异丙肾上腺素[1]。
与未预处理的致敏小鼠相比,CV-6209(66 微克;静脉注射)可降低天冬酰胺酶诱导的超敏反应[3]。
热销产品:Kaempferol | Almonertinib | FITC-Dextran (MW 40000) | ONO-AE3-208 | NMDA | MS159 | Salvianolic acid A | Histamine | Cucurbitacin I | Estradiol 17-(β-D-Glucuronide) (sodium)
研究领域:GPCR/G Protein
作用靶点:Platelet-activating Factor Receptor (PAFR)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
参考文献:
[1]. Terashita Z, et, al. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. J Pharmacol Exp Ther. 1987 Jul;242(1):263-8.
[2]. Munoz-Cano R, et, al. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study). J Investig Allergol Clin Immunol. 2017;27(3):161-168.
[3]. Fernande CA, et, al. Effect of premedications in a murine model of asparaginase hypersensitivity. J Pharmacol Exp Ther. 2015 Mar;352(3):541-51.